Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRVB

Provention Bio (PRVB) Stock Price, News & Analysis

Provention Bio logo

About Provention Bio Stock (NASDAQ:PRVB)

Advanced Chart

Key Stats

Today's Range
$24.98
$24.98
50-Day Range
$23.74
$24.98
52-Week Range
$3.18
$25.00
Volume
218,200 shs
Average Volume
2.28 million shs
Market Capitalization
$2.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provention Bio and its competitors with MarketBeat's FREE daily newsletter.

PRVB Stock News Headlines

Macrogenics Inc MGNX
Jeff Bezos Launches "ChatGPT Killer"?
Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% of his time focused on AI… but Nova is only part of the story. Behind the scenes, Amazon has been quietly investing in a breakthrough called “Helios” tech—a core enabler of the $40 trillion AI revolution. While Nova grabs headlines, this technology could be what truly transforms Amazon’s future. But one tiny startup—not Amazon—may offer the bigger upside.
Sanofi completes Provention Bio acquisition
See More Headlines

PRVB Stock Analysis - Frequently Asked Questions

Provention Bio, Inc. (NASDAQ:PRVB) posted its earnings results on Thursday, November, 4th. The company reported ($0.43) EPS for the quarter, topping the consensus estimate of ($0.51) by $0.08. The company earned $0.68 million during the quarter, compared to the consensus estimate of $3.75 million. Provention Bio had a negative net margin of 880.69% and a negative trailing twelve-month return on equity of 103.36%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provention Bio investors own include NVIDIA (NVDA), NIO (NIO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Meta Platforms (META), VBI Vaccines (VBIV) and Amarin (AMRN).

Company Calendar

Last Earnings
11/04/2021
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PRVB
CIK
1695357
Fax
N/A
Employees
82
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$113.57 million
Net Margins
-880.69%
Pretax Margin
-984.54%
Return on Equity
-103.36%
Return on Assets
-69.08%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
1.93
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$12.90 million
Price / Sales
183.54
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.40 per share
Price / Book
17.84

Miscellaneous

Outstanding Shares
94,780,000
Free Float
82,365,000
Market Cap
$2.37 billion
Optionable
Not Optionable
Beta
2.47
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PRVB) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners